Information Provided By:
Fly News Breaks for January 31, 2020
Jan 31, 2020 | 09:25 EDT
RBC Capital analyst Brian Abrahams raised his price target on Vertex to $260 and kept his Outperform rating. The analyst believes that the optimism for its commercial execution in 2020 should be sustained by the company's "strong" Trikafta launch, with orders of magnitude above consensus expectations. Abrahams adds that Vertex offers a "unique" high-growth/low risk" profile and remaining pipeline optionality.